Review





Similar Products

90
Novus Biologicals mouse anti-somatostatin nbp2-37447
Mouse Anti Somatostatin Nbp2 37447, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-somatostatin nbp2-37447/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
mouse anti-somatostatin nbp2-37447 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti β catenin
Anti β Catenin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti β catenin/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti β catenin - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti β catenin antibody
Figure 6. Western blot analysis of the effect of rhAgrin treatment on human articular chondrocytes. (A) At the whole protein level, the expression <t>of</t> <t>β-catenin,</t> RUNX2, and SOX9 were increased after rhAgrin treatment. (B) Analysis of nuclear extraction protein also showed that the expression of both β-catenin and SOX9 were increased after rhAgrin treatment. In contrast, analysis of nuclear extraction protein showed no significant difference in the expression of NF-κB p65. * p < 0.05, ** p < 0.01, ns: not significant.
Anti β Catenin Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti β catenin antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti β catenin antibody - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Western blot analysis of the effect of rhAgrin treatment on human articular chondrocytes. (A) At the whole protein level, the expression of β-catenin, RUNX2, and SOX9 were increased after rhAgrin treatment. (B) Analysis of nuclear extraction protein also showed that the expression of both β-catenin and SOX9 were increased after rhAgrin treatment. In contrast, analysis of nuclear extraction protein showed no significant difference in the expression of NF-κB p65. * p < 0.05, ** p < 0.01, ns: not significant.

Journal: International journal of molecular sciences

Article Title: LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes.

doi: 10.3390/ijms26031007

Figure Lengend Snippet: Figure 6. Western blot analysis of the effect of rhAgrin treatment on human articular chondrocytes. (A) At the whole protein level, the expression of β-catenin, RUNX2, and SOX9 were increased after rhAgrin treatment. (B) Analysis of nuclear extraction protein also showed that the expression of both β-catenin and SOX9 were increased after rhAgrin treatment. In contrast, analysis of nuclear extraction protein showed no significant difference in the expression of NF-κB p65. * p < 0.05, ** p < 0.01, ns: not significant.

Article Snippet: The membranes were incubated with Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln, NE, USA) for 1 h at room temperature and then incubated overnight at 4 ◦C with anti-SOX9 antibody (1:5000, ab185230, Abcam, Cambridge, UK), anti-β-catenin antibody (1:1000, #37447, Cell Signaling Technology), anti-RUNX2 antibody (1:1000, #12556, Cell Signaling Technology), or anti-NF-kB p65 (1:1000, #8242, Cell Signaling Technology) as the primary antibody.

Techniques: Western Blot, Expressing, Extraction

Figure 5. Immunocytochemical evaluation of the effect of rhAgrin treatment on human articular chondrocytes. (A) Double immunocytochemical staining of β-catenin and SOX9 nuclear translocation. (B) Translocation to nuclei of both β-catenin and SOX9 was increased after rhAgrin treatment. * p < 0.001. Scale bar = 100 µm.

Journal: International journal of molecular sciences

Article Title: LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes.

doi: 10.3390/ijms26031007

Figure Lengend Snippet: Figure 5. Immunocytochemical evaluation of the effect of rhAgrin treatment on human articular chondrocytes. (A) Double immunocytochemical staining of β-catenin and SOX9 nuclear translocation. (B) Translocation to nuclei of both β-catenin and SOX9 was increased after rhAgrin treatment. * p < 0.001. Scale bar = 100 µm.

Article Snippet: The membranes were incubated with Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln, NE, USA) for 1 h at room temperature and then incubated overnight at 4 ◦C with anti-SOX9 antibody (1:5000, ab185230, Abcam, Cambridge, UK), anti-β-catenin antibody (1:1000, #37447, Cell Signaling Technology), anti-RUNX2 antibody (1:1000, #12556, Cell Signaling Technology), or anti-NF-kB p65 (1:1000, #8242, Cell Signaling Technology) as the primary antibody.

Techniques: Staining, Translocation Assay

Figure 7. Combined effects of Agrin knockdown and intense CTS on β-catenin expression analyzed by Western blot. Expression of β-catenin was increased 24 h after application of intense CTS, but the siAGRN transfection + intense CTS group showed a trend towards reduced nuclear expression of β-catenin. * p < 0.001, ** p < 0.0001.

Journal: International journal of molecular sciences

Article Title: LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes.

doi: 10.3390/ijms26031007

Figure Lengend Snippet: Figure 7. Combined effects of Agrin knockdown and intense CTS on β-catenin expression analyzed by Western blot. Expression of β-catenin was increased 24 h after application of intense CTS, but the siAGRN transfection + intense CTS group showed a trend towards reduced nuclear expression of β-catenin. * p < 0.001, ** p < 0.0001.

Article Snippet: The membranes were incubated with Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln, NE, USA) for 1 h at room temperature and then incubated overnight at 4 ◦C with anti-SOX9 antibody (1:5000, ab185230, Abcam, Cambridge, UK), anti-β-catenin antibody (1:1000, #37447, Cell Signaling Technology), anti-RUNX2 antibody (1:1000, #12556, Cell Signaling Technology), or anti-NF-kB p65 (1:1000, #8242, Cell Signaling Technology) as the primary antibody.

Techniques: Knockdown, Expressing, Western Blot, Transfection

Figure 10. Modulation of LRP4 and Agrin under the current experimental conditions focusing on β-catenin signaling in human articular chondrocytes. Mild mechanical stress upregulated (↑) LRP4 expression in the superficial layer. Intense mechanical stress increased (↑) Agrin expression, leading to situations similar to LRP4 downregulation or LRP4 knockdown (↓), and then upregulated (↑) β-catenin translocation via LRP5/6. The LRP4 knockdown experiments showed that LRP4 negatively regulated LRP5/6 expression. FZD—Frizzled; SOST—Sclerostin; DKK1—Dickkopf-1.

Journal: International journal of molecular sciences

Article Title: LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes.

doi: 10.3390/ijms26031007

Figure Lengend Snippet: Figure 10. Modulation of LRP4 and Agrin under the current experimental conditions focusing on β-catenin signaling in human articular chondrocytes. Mild mechanical stress upregulated (↑) LRP4 expression in the superficial layer. Intense mechanical stress increased (↑) Agrin expression, leading to situations similar to LRP4 downregulation or LRP4 knockdown (↓), and then upregulated (↑) β-catenin translocation via LRP5/6. The LRP4 knockdown experiments showed that LRP4 negatively regulated LRP5/6 expression. FZD—Frizzled; SOST—Sclerostin; DKK1—Dickkopf-1.

Article Snippet: The membranes were incubated with Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln, NE, USA) for 1 h at room temperature and then incubated overnight at 4 ◦C with anti-SOX9 antibody (1:5000, ab185230, Abcam, Cambridge, UK), anti-β-catenin antibody (1:1000, #37447, Cell Signaling Technology), anti-RUNX2 antibody (1:1000, #12556, Cell Signaling Technology), or anti-NF-kB p65 (1:1000, #8242, Cell Signaling Technology) as the primary antibody.

Techniques: Expressing, Knockdown, Translocation Assay